Ixchiq (Chikungunya vaccine (live-attenuated)) - lifting of temporary contraindication in adults 65 years and older; warning on severe adverse reactions, including encephalitis
19/09/2025
Medicines for human use
Direct healthcare professional communication (DHPC)
Important Safety Information from Valneva Austria GmbH regarding Ixchiq (Chikungunya vaccine (live-attenuated)): lifting of temporary contraindication in adults 65 years and older; warning on severe adverse reactions, including encephalitis